US Patent Issued to TAIWAN LIPOSOME, TLC BIOPHARMACEUTICALS on May 19 for "Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof" (California Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,354, issued on May 19, was assigned to TAIWAN LIPOSOME Co. LTD. (Taipei City, Taiwan) and TLC BIOPHARMACEUTICALS INC. (South San Francisco, Calif.).

"Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof" was invented by Keelung Hong (South San Francisco, Calif.), Walter Gwathney (South San Francisco, Calif.), Hao-wen Kao (South San Francisco, Calif.) and Yi-yu Lin (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising at least one liposome, a trapping agent and a sedative drug with a high drug to lipid ratio and a high...